AQR Capital Management - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$706,000
-14.3%
961,460
+8.9%
0.00%0.0%
Q1 2020$824,000
-70.5%
883,253
-35.6%
0.00%
-66.7%
Q4 2019$2,797,000
+44.0%
1,371,236
+102.6%
0.00%
+50.0%
Q3 2019$1,943,000
+6.9%
676,843
+185.7%
0.00%0.0%
Q2 2019$1,817,000
-51.3%
236,927
-15.5%
0.00%
-50.0%
Q1 2019$3,728,000
+43.8%
280,486
+68.6%
0.00%
+33.3%
Q4 2018$2,592,000
+8.6%
166,349
+36.9%
0.00%
+50.0%
Q3 2018$2,386,000
+267.1%
121,471
+436.3%
0.00%
+100.0%
Q2 2018$650,000
-65.0%
22,649
-71.2%
0.00%
-50.0%
Q1 2018$1,858,000
-77.8%
78,575
-79.9%
0.00%
-77.8%
Q4 2017$8,381,000
+52.2%
390,717
+67.8%
0.01%
+28.6%
Q3 2017$5,506,000
+23.6%
232,810
+3.0%
0.01%
+16.7%
Q2 2017$4,453,000
+63.8%
226,037
+74.6%
0.01%
+50.0%
Q1 2017$2,719,000
+65.6%
129,458
+48.3%
0.00%
+100.0%
Q4 2016$1,642,000
-0.7%
87,304
+10.2%
0.00%
-33.3%
Q3 2016$1,654,000
-11.4%
79,241
+8.3%
0.00%0.0%
Q2 2016$1,866,000
+52.0%
73,151
+57.5%
0.00%
+50.0%
Q1 2016$1,228,000
-30.9%
46,439
-12.9%
0.00%
-50.0%
Q2 2015$1,776,000
-48.3%
53,306
-48.4%
0.00%
-50.0%
Q1 2015$3,436,000
+4.9%
103,237
+28.8%
0.01%
+14.3%
Q4 2014$3,276,000
+98.4%
80,164
+64.5%
0.01%
+40.0%
Q3 2014$1,651,000
-17.4%
48,720
-17.9%
0.01%0.0%
Q2 2014$2,000,000
-6.8%
59,320
+4.8%
0.01%
-16.7%
Q1 2014$2,146,000
+54.4%
56,609
+18.9%
0.01%
+50.0%
Q4 2013$1,390,000
-34.2%
47,609
-22.7%
0.00%
-42.9%
Q3 2013$2,112,000
+112.7%
61,609
+104.6%
0.01%
+75.0%
Q2 2013$993,00030,1090.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,044,783$34,770,0004.41%
1492 Capital Management LLC 101,582$3,381,0001.96%
Tekla Capital Management LLC 680,862$22,659,0000.90%
ARBOR CAPITAL MANAGEMENT LLC 186,495$6,207,0000.74%
HUSSMAN STRATEGIC ADVISORS, INC. 210,000$6,989,0000.73%
Pergamon Offshore Advisors, L.P. 18,711$623,0000.60%
Partner Investment Management, L.P. 11,594$386,0000.58%
Penn Capital Management Company, LLC 426,937$14,208,0000.56%
HighPoint Advisor Group LLC 10,609$360,0000.55%
EAGLE ASSET MANAGEMENT INC 2,461,980$81,934,0000.47%
View complete list of ACORDA THERAPEUTICS INC shareholders